Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gradual Remifentanil Withdrawal for Postoperative Pain in Breast Surgery
NCT03756233Completed
- Sponsor
- Samsung Medical Center
- Start
- Nov 2018
- Primary completion
- Jul 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of remifentanil in postoperative pain, sponsored by Samsung Medical Center. Primary endpoint: Numeric Rating Scale at 1 hour. Started Nov 2018; status: completed.
02
Drugs
remifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03756233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756233.